Danaher Corporation (DHR) Upgraded to Buy by Zacks Investment Research

Zacks Investment Research upgraded shares of Danaher Corporation (NYSE:DHR) from a hold rating to a buy rating in a research report released on Thursday morning. The brokerage currently has $97.00 price target on the conglomerate’s stock.

According to Zacks, “Year-to-date, Danaher’s shares have outperformed the industry’s average return. The company has an excellent earnings history over the trailing four quarters, beating estimates all through. We are optimistic about the company’s core revenue and earnings growth, on the back of improving order trends and its operating culture, DBS. Going forward, the company expects the biopharma business to be a major growth driver. Its recent acquisitions – Pall and Cepheid – are proving to be strong profit churners, and will boost top-line growth as they become a part of the company’s core revenues. However, on the flip side, slowdown in the company’s academic business in Europe and prolonged sluggishness in the Dental business has restricted growth. Weakness in industrial markets and stiff competition may also hurt the company's financials.”

DHR has been the subject of a number of other reports. Deutsche Bank AG reiterated a buy rating and issued a $97.00 target price on shares of Danaher Corporation in a research note on Wednesday, June 21st. Wells Fargo & Company started coverage on shares of Danaher Corporation in a research note on Thursday, July 13th. They issued a market perform rating and a $90.00 target price for the company. BidaskClub cut shares of Danaher Corporation from a hold rating to a sell rating in a research note on Saturday, July 8th. Jefferies Group LLC reiterated a buy rating and issued a $95.00 target price on shares of Danaher Corporation in a research note on Friday, August 4th. Finally, Goldman Sachs Group, Inc. (The) reiterated a neutral rating and issued a $83.00 target price on shares of Danaher Corporation in a research note on Tuesday, September 26th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of Buy and an average target price of $92.62.

Shares of Danaher Corporation (DHR) opened at 87.63 on Thursday. The firm has a market cap of $60.88 billion, a price-to-earnings ratio of 27.97 and a beta of 1.03. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.62. The stock has a 50 day moving average of $85.07 and a 200 day moving average of $84.19.

Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.90 earnings per share. Equities analysts predict that Danaher Corporation will post $3.95 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Danaher Corporation (DHR) Upgraded to Buy by Zacks Investment Research” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://ledgergazette.com/2017/10/09/danaher-corporation-dhr-upgraded-to-buy-by-zacks-investment-research.html.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be given a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s dividend payout ratio is 17.83%.

In related news, insider William King sold 43,688 shares of the business’s stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the transaction, the insider now owns 45,748 shares of the company’s stock, valued at $3,790,679.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the transaction, the insider now directly owns 155,520 shares in the company, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. Insiders have sold 71,496 shares of company stock worth $5,916,223 in the last ninety days. 12.20% of the stock is currently owned by insiders.

Hedge funds have recently made changes to their positions in the stock. Honeywell International Inc. bought a new position in Danaher Corporation during the second quarter worth $25,317,000. Israel Discount Bank of New York bought a new position in Danaher Corporation during the first quarter worth $209,000. Eastern Bank increased its position in Danaher Corporation by 4,291.1% during the second quarter. Eastern Bank now owns 128,001 shares of the conglomerate’s stock worth $10,802,000 after acquiring an additional 125,086 shares during the period. DE Burlo Group Inc. increased its position in Danaher Corporation by 17.8% during the first quarter. DE Burlo Group Inc. now owns 131,450 shares of the conglomerate’s stock worth $11,242,000 after acquiring an additional 19,900 shares during the period. Finally, Perkins Coie Trust Co increased its position in Danaher Corporation by 2.0% during the second quarter. Perkins Coie Trust Co now owns 29,431 shares of the conglomerate’s stock worth $2,484,000 after acquiring an additional 586 shares during the period. 75.69% of the stock is currently owned by institutional investors and hedge funds.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identificat

According to Zacks, “Year-to-date, Danaher’s shares have outperformed the industry’s average return. The company has an excellent earnings history over the trailing four quarters, beating estimates all through. We are optimistic about the company’s core revenue and earnings growth, on the back of improving order trends and its operating culture, DBS. Going forward, the company expects the biopharma business to be a major growth driver. Its recent acquisitions – Pall and Cepheid – are proving to be strong profit churners, and will boost top-line growth as they become a part of the company’s core revenues. However, on the flip side, slowdown in the company’s academic business in Europe and prolonged sluggishness in the Dental business has restricted growth. Weakness in industrial markets and stiff competition may also hurt the company's financials.”

DHR has been the subject of a number of other reports. Deutsche Bank AG reiterated a buy rating and issued a $97.00 target price on shares of Danaher Corporation in a research note on Wednesday, June 21st. Wells Fargo & Company started coverage on shares of Danaher Corporation in a research note on Thursday, July 13th. They issued a market perform rating and a $90.00 target price for the company. BidaskClub cut shares of Danaher Corporation from a hold rating to a sell rating in a research note on Saturday, July 8th. Jefferies Group LLC reiterated a buy rating and issued a $95.00 target price on shares of Danaher Corporation in a research note on Friday, August 4th. Finally, Goldman Sachs Group, Inc. (The) reiterated a neutral rating and issued a $83.00 target price on shares of Danaher Corporation in a research note on Tuesday, September 26th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of Buy and an average target price of $92.62.

Shares of Danaher Corporation (DHR) opened at 87.63 on Thursday. The firm has a market cap of $60.88 billion, a price-to-earnings ratio of 27.97 and a beta of 1.03. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.62. The stock has a 50 day moving average of $85.07 and a 200 day moving average of $84.19.

Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.90 earnings per share. Equities analysts predict that Danaher Corporation will post $3.95 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Danaher Corporation (DHR) Upgraded to Buy by Zacks Investment Research” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://ledgergazette.com/2017/10/09/danaher-corporation-dhr-upgraded-to-buy-by-zacks-investment-research.html.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be given a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s dividend payout ratio is 17.83%.

In related news, insider William King sold 43,688 shares of the business’s stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the transaction, the insider now owns 45,748 shares of the company’s stock, valued at $3,790,679.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the transaction, the insider now directly owns 155,520 shares in the company, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. Insiders have sold 71,496 shares of company stock worth $5,916,223 in the last ninety days. 12.20% of the stock is currently owned by insiders.

Hedge funds have recently made changes to their positions in the stock. Honeywell International Inc. bought a new position in Danaher Corporation during the second quarter worth $25,317,000. Israel Discount Bank of New York bought a new position in Danaher Corporation during the first quarter worth $209,000. Eastern Bank increased its position in Danaher Corporation by 4,291.1% during the second quarter. Eastern Bank now owns 128,001 shares of the conglomerate’s stock worth $10,802,000 after acquiring an additional 125,086 shares during the period. DE Burlo Group Inc. increased its position in Danaher Corporation by 17.8% during the first quarter. DE Burlo Group Inc. now owns 131,450 shares of the conglomerate’s stock worth $11,242,000 after acquiring an additional 19,900 shares during the period. Finally, Perkins Coie Trust Co increased its position in Danaher Corporation by 2.0% during the second quarter. Perkins Coie Trust Co now owns 29,431 shares of the conglomerate’s stock worth $2,484,000 after acquiring an additional 586 shares during the period. 75.69% of the stock is currently owned by institutional investors and hedge funds.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Get a free copy of the Zacks research report on Danaher Corporation (DHR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply